Stay updated on Safety of Ascending Doses in Dravet Syndrome Clinical Trial
Sign up to get notified when there's something new on the Safety of Ascending Doses in Dravet Syndrome Clinical Trial page.

Latest updates to the Safety of Ascending Doses in Dravet Syndrome Clinical Trial page
- Check5 days agoChange DetectedAdded a Publications section with a 2026 NEJM article citation (Zorevunersen in Dravet Syndrome) and PubMed attribution, and noted a revision to version v3.4.3.SummaryDifference0.3%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added; older notices about funding lapse and NIH operating status were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedThe page now displays a government funding/status notice at the top and the revision label was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check48 days agoChange DetectedUI labels and version metadata were updated (Show glossary added, capitalization/wording tweaks for QC labels, Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision history shows addition of Revision: v3.3.4 and removal of Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedLocations section updated with new state entries and the version tag changed to v3.3.3. The previous state locations and the HHS Vulnerability Disclosure text were removed.SummaryDifference2%

Stay in the know with updates to Safety of Ascending Doses in Dravet Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Ascending Doses in Dravet Syndrome Clinical Trial page.